(Q51666148)

9 April 2018

title

Prognostic values of ERK1/2 and p-ERK1/2 expressions for poor survival in non-small cell lung cancer. (English)

1 reference

9 April 2018

author name string

Shuang Zhao

1

1 reference

9 April 2018

Zhi-xin Qiu

2

1 reference

9 April 2018

Li Zhang

3

1 reference

9 April 2018

Wei-min Li

4

1 reference

9 April 2018

publication date

18 January 2015

1 reference

9 April 2018

published in

Tumor Biology

1 reference

9 April 2018

volume

36

1 reference

9 April 2018

issue

6

1 reference

9 April 2018

page(s)

4143-4150

1 reference

9 April 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-3048-4

exact match

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Evidence for new standard of care in non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

A decade of advances in treatment for advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Early lung cancer: methods for detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Towards a biological staging model for operable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Novel targets for lung cancer therapy: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Molecular predictive and prognostic markers in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Novel agents and strategies for overcoming EGFR TKIs resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

New pathologic classification of lung cancer: relevance for clinical practice and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Significance of decoy receptor 3 (Dcr3) and external-signal regulated kinase 1/2 (Erk1/2) in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3048-4

21 January 2018

Pathology of lung cancer

1 reference

12 December 2020

Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells

1 reference

12 December 2020

MEK and the inhibitors: from bench to bedside

1 reference

12 December 2020

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers

1 reference

12 December 2020

The Royal College of Radiologists Clinical Oncology Information Network. Guidelines on the non-surgical management of lung cancer

1 reference

12 December 2020

Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments

1 reference

12 December 2020

Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations

1 reference

12 December 2020

Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma

1 reference

12 December 2020

Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.

1 reference

12 December 2020

Expression of aquaporin 8 and phosphorylation of Erk1/2 in cervical epithelial carcinogenesis: correlation with clinicopathological parameters

1 reference

12 December 2020

Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions

1 reference

12 December 2020

10.1007/S13277-015-3048-4

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

25596700

1 reference

9 April 2018